pc ¹öÀüÀ¸·Î À̵¿ Áß [½ÃÀ庸°í¼­]¹ÙÀÌ¿ÀÀǾàǰ ¼öŹÁ¦Á¶±â°ü(BCMO) ½ÃÀå(2022³â)
¹ÙÀÌ¿ÀÀǾàǰ ¼öŹÁ¦Á¶±â°ü(BCMO) ½ÃÀå(2022³â)
Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
»óǰÄÚµå : 1109058
¸®¼­Ä¡»ç : Kalorama Information
¹ßÇàÀÏ : 2022³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
US $ 6,000 £Ü 7,466,000
Online Access (Single User License)
US $ 9,000 £Ü 11,199,000
Online Access & PDF Download (10 Users)
US $ 12,000 £Ü 14,932,000
Online Access & PDF Download (Unlimited Users)


Çѱ۸ñÂ÷

¹ÙÀÌ¿ÀÀǾàǰ ¼öŹÁ¦Á¶±â°ü(BCMO : Biopharmaceutical Contract Manufacturing Organization) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, BCMO °³¿ä, ±â¼ú µ¿Çâ, ½ÃÀå ±Ô¸ð ÃßÁ¤°ú ¿¹Ãø, °¢Á¾ ºÎ¹®¡¤Áö¿ª/ÁÖ¿ä ±¹°¡º° ³»¿ª, ÁÖ¿ä ±â¾÷ °³¿ä µîÀ» Á¤¸®Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå °³¿ä

Á¦3Àå ¼öŹÁ¦Á¶¾÷

Á¦4Àå ¼¼°èÀÇ BCMO ½ÃÀå

Á¦5Àå BCMO ½ÃÀå : Áö¿ªº°

Á¦6Àå Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ °³¿ä

KSM 22.10.11
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

This report, “Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022 ”, describes and discusses the global contract manufacturing markets, specifically focusing on the production of biotech (large molecule) products including extensive coverage of the biotechnology segment of the global BCMO industry. Sales estimates are provided by segment and region, expressed in current dollars. Estimates are provided for the historic 2016 to 2021 period and forecasts are provided through 2026.

Further, this report examines third party manufacturing of potential and commercialized prescription drug products throughout the world. Potential drug products are those in clinical (Phase I - Phase III) testing prior to regulatory approval and require relatively small amounts of product for these evaluations; commercialized drugs are those which have received regulatory approval and have been introduced to mass markets. In some cases, drugs have received regulatory approval in selected regions (such as the EU, but not in others such as the US).

The report contains the following market information:

Companies covered in this report include:

  • 3p Biopharmaceuticals
  • 3sbio Group/Shenyang Sunshine Pharmaceuticals Co., Ltd.
  • Abbvie
  • Aenova
  • Agc Biologics
  • Ajinomoto Bio-Pharma Services
  • Anemocyte
  • Asahi Glass Co.
  • Aurobindo
  • Avara Pharmaceutical Services
  • Bachem
  • Baxter Biopharma Solutions
  • Boehringer Ingelheim Bioxcellence
  • Bora Pharmaceuticals
  • Catalent
  • Cellipoint Bioservices
  • Celonic Ag
  • Charles River Labs/Cognate Bioservices
  • Cordenpharma
  • Curia
  • Cytiva/Danaher
  • Cytovance Biologics
  • Reddy's Laboratories
  • Evonik
  • Excellgene
  • Fareva
  • Fresenius Kabi Product Partnering
  • Fujifilm Diosynth Biotechnologies
  • Grifols
  • Idifarma
  • Jubilant Biosys
  • Kemwell Biopharma
  • Lfb Sa
  • Lonza
  • Luinabio
  • Matica Biotechnology/Cha Biotech
  • Menarini Biotech
  • Novasep
  • Lubrizol Life Science Health
  • Millipore Sigma/Bioreliance/Merck Kgaa
  • Minaris Regenerative Medicine
  • Novartis
  • Oxford Biomedica
  • Patheon/Thermo Fisher Scientific
  • Pci Pharma Services
  • Pfizer Centreone
  • Piramal Pharma Solutions
  • Pluristyx
  • Porton Biologics
  • Recipharm
  • Rentschler Biotechnologie Gmbh
  • Resilience
  • Rovi Contract Manufacturing
  • Samsung Biologics
  • Siegfried Ag
  • Sl Pharma Labs
  • Stelis Biopharma/Strides Shashun Ltd.
  • Stgen Bio
  • Symbiosis Pharmaceutical Services
  • Syngene International
  • Takara Bio
  • Takeda
  • Tcg Lifesciences
  • Teuto
  • The Center For Breakthrough Medicines
  • Tianjin Pharmaceutical
  • Upm Pharmaceuticals
  • Vetter Pharma International Gmbh
  • Vibalogics
  • Woodfield Pharmaceutical
  • Wuxi Apptec
  • Yposkesi

Table of Contents

Chapter 1: Executive Summary

Chapter 2: Overview

Chapter 3: The Contract Manufacturing Industry

Chapter 4: Total Global BCMO Market

Chapter 5: The BCMO Market by Region

Chapter 6: Pharmaceutical & Biotech Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â